SCHEMBL12670548

SCHEMBL12670548

Cc1cc(C(F)(F)F)ccc1S(=O)(=O)Nc1ccc(Sc2nc3cc(Cl)ccc3s2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
GAA P10253 4/20 0.50
POLB P06746 1/20 0.50
TP53 P04637 2/20 0.45
LMNA P02545 4/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALOX12 P18054 1/20 0.44
MCL1 Q07820 2/20 0.43
CDK1 P06493 1/20 0.42
CCNB1 P14635 1/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
CDK7 P50613 1/20 0.42
CCNH P51946 1/20 0.42
CCNA1 P78396 1/20 0.42
IDH1 O75874 6/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2742720 0.93 MAPT (0.51) MAPTGAAPOLBTP53LMNA
SCHEMBL2030411 0.91 MAPT (0.51) MAPTGAAPOLBTP53LMNA
SCHEMBL2036273 0.88 MAPT (0.47) MAPTGAAPOLBTP53LMNA
SCHEMBL2034633 0.85 MAPT (0.47) MAPTGAAPOLBTP53LMNA
SCHEMBL12670163 0.83 GAA (0.56) MAPTGAAPOLBTP53LMNA
SCHEMBL12670833 0.83 MEN1 (0.49) MAPTGAAPOLBTP53LMNA
SCHEMBL12670142 0.82 MCL1 (0.51) MAPTGAAPOLBTP53LMNA
SCHEMBL2031022 0.82 MAPT (0.42) MAPTGAAPOLBTP53LMNA
SCHEMBL2033632 0.80 PPARG (0.45) MAPTGAAPOLBLMNAMEN1
SCHEMBL2029584 0.79 SGK1 (0.43) MAPTGAAPOLBTP53LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7939551-B2 for diabetes mellitus and other metabolic disorders; compounds of given formula such as sulfonamides and an antidiabetic agent such as sulfonylureas, biguanides, glitazones, alpha-glucosidase inhibitors, glucagon antagonists AMGEN INC. (US) 2011-05-10 US disclosed